Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Antibiotics Pharmacokinetics and Efficacy, and Antibiotic Resistance in Bacteria.
A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease
Population-Based Screening for Chronic Obstructive Pulmonary Disease Using the St. George’s Respiratory Questionnaire in Resource-Limited Settings
RCT Abstract - Budesonide/glycopyrronium/formoterol fumarate dihydrate triple therapy for inadequately-controlled asthma: KALOS and LOGOS study results
ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD
Patient Insights on Living With Type 2 Inflammation: A Community Survey
Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement
Early Evidence of Chronic Obstructive Pulmonary Disease Obscured by Race-Specific Prediction Equations
The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control
Use of the Spirometric “Fixed-Ratio” Underdiagnoses COPD in African-Americans in a Longitudinal Cohort Study
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function
Time‐Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial
Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings
An Online Weight Loss Intervention for People With Obesity and Poorly Controlled Asthma
Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease
Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical Trial
The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations
Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD
Roflumilast May Increase Risk of Exacerbations When Used to Treat Poorly Controlled Asthma in People with Obesity
Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD
Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies
Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease
The influence of social support on COPD outcomes mediated by depression
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations
The Use of Inhaled Corticosteroids for Patients with COPD Who Continue to Smoke Cigarettes: An Evaluation of Current Practice
Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial
Discordant diagnostic criteria for pneumonia in COPD trials: a review
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis